NCT02470390View on ClinicalTrials.gov

Open Label Crossover Study Pharmacokinetics (PK) Study in Healthy Volunteers Receiving Various Forms of Fentanyl

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

April 30, 2015

Conditions
Healthy
Interventions
DRUG

Fentanyl

Lazanda (nasal spray), Subsys (sub-lingual) and intravenous fentanyl

Sponsors

Lead Sponsor

Depomed
All Listed Sponsors
lead

Depomed

INDUSTRY

NCT02470390 - Open Label Crossover Study Pharmacokinetics (PK) Study in Healthy Volunteers Receiving Various Forms of Fentanyl | Biotech Hunter | Biotech Hunter